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Abstract 
Background:  Several breeds have physiological peculiarities that induce variations in 
reference intervals compared to the general canine population. Shetland sheepdogs are 
reported to be more predisposed to different diseases (e.g. hyperlipidemia, 
gallbladder mucocele, hypothyroidism). Consequently, a breed-specific approach is more 
often required. 
Objectives: The aim of this study is to determine whether reference intervals (RI) of the 
general canine population may be applied to Shetland Sheepdogs (SS), and 
to generate breed-specific reference intervals, where appropriate. 
Methods: Sixty clinically healthy fasted dogs (36% of the population registered at 
the Italian Breed association), were 
examined. Routine hematology and biochemistrywere performed. The transference 
method was used to compare the results of SS with the RIs of the general canine 
population. When these RIs were not validated, newRIs were generated according to the 
guidelines of the American Society of Veterinary Clinical Pathology. 
Differences associated with sex, age, coat color and use were also investigated.  
Results: The transference method validated 30/38 RIs. For 6 of the 
remaining 8 analytes, the difference with the claimed RIs could depend on pre-analytical 
or analytical artefacts whereas for glucose and total cholesterol these differences may 
depend on breed peculiarities. However, in all the dogs the concentration of cholesterol 
was <500 mg/dL. Relevant differences associated with sex, age, coat color and use were 
not found. 
Conclusions: This study suggests that breed-specific RIs should be used for glucose 
and cholesterol in SS. 
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Introduction 
Shetland Sheepdog (FCI-Standard N° 88) takes his origins from Great Britain and is 
included in the Group 1 (Sheepdogs and Cattle dogs) according to 
the FédérationCynologique Internationale breeds 
classification.1 The Shetland Sheepdog can be considered as a companion dog as well 
as a sheepdog, but an increasing number of these dogs is nowadays excelling in agility 
competitions. The number of dogs registered at the Italian National Kennel Club 
(ENCI, Ente Nazionale Cinofilia Italiana) has doubled in the last nine years.2 
This breed is reported to be predisposed to different diseases, such 
as primary hyperlipidemia,3 gallbladder mucocele (GM),4 hypothyroidism,5 Multi-Drug 
Resistance(MDR-1) mutation.6 
Hyperlipidemia is an increased concentration of lipids (triglycerides, cholesterol, or both) in 
blood that may be as high as 500 mg/dL.7 It has been reported or suspected to be more 
prevalent in certain canine breeds such as Miniature Schnauzer,8 but, 
if constitutively present also in Shetland Sheepdogs, may generate problems in 
theinterpretation of patient’s blood tests, when reference intervals (RIs) referred to the 
general canine population are used. No information is available about the need to 
establish breed-specific RIs for Shetland Sheepdogs. However, the establishment of these 
RIs should be the first step to better explain laboratory data from this breed and to better 
diagnose some diseases reported in Shetland sheepdogs, such as primary hyperlipidemia 
and GM. In fact, several breeds have physiological peculiarities that induce variations in 
RIs compared to the general canine population.9,10 and in these breeds clinical 
decisions must often be based on the comparison between patient’s laboratory results and 
breed-specific RIs.  
The aim of this study is to determine whether RIs referred to the general canine 
population may be applied to Shetland Sheepdogs from Italy, and to determine breed-
specific RIs, when the general RIs were not validated, following the guidelines published 
by the American Society of Veterinary Clinical Pathology (ASVCP).11 In addition, we 
investigated whether sex, use, age or coat color could influence hematological and 
biochemical variables in this breed. 
  
Materials and methods 
Study design and sample collection 
All the dogs included in this study were privately-owned and lived in North of Italy. The 
study was approved by the Ethical Committee of our Institution (approval 
number: OBPA 1/2016) and an informed consent was obtained from the owners of the 
dogs. Blood was collected from the cephalic vein using a 2,5 mL syringe connected to a 
butterfly needle; One ml of blood has been immediately placed into EDTA tubes with the 
maximum capacity of 1 mL (Miniplast; LP Italiana S.p.A., Italy) for routine hematology, 
whereas the remnant blood was transferred into a plain tube (Vacuette; Greiner Bio-One GmbH, 
Austria) with the maximum capacity of 5 mL. After 10 minutes, plain tubes were 
centrifuged at 3500 rpm for 5 minutes to obtain serum that was transferred to plain conic 
tubes (Eppendorf, Germany) and frozen at -20°C. Within a maximum of 6 hours, 
immediately after arrival in the laboratory, the complete cell blood count (CBC) was 
performed, and serum was stocked at -20°C for the execution of the biochemical analysis 
within 1 week. Samples were collected during breeder meetings or before agility 
competitions from 12 hours-fasted animals, after the collection of history and of clinical 
information and after a complete physical examination. Agility competitions were 
performed 5 hours after sampling, to enable to feed the dogs.  
The inclusion criteria for this study were (1) age range: 1-8 years, (2) absence of 
external clinical signs or evidence of disease, (3) absence of clinical signs in the history. 
The exclusion criteria were (1) pregnancy, (2) presence of clinical signs of disease, (3) use 
of medications except anti-parasitic treatments, (4) sample’s alterations that can interfere 
with the analysis, such as icterus or hemolysis, presence of clots in EDTA 
samples. Lipemia in clinically healthy and fasted dogs was not considered “a priori” as an 
exclusion criterion since one of the aim of the study was to assess the normal lipid 
concentration in Shetland Sheepdogs, that are known to be potentially hyperlipemic. 
  
Analytical methods 
Hematology: the CBC was performed using an automated laser-
based hematology analyser (Sysmex XT-2000iV; Sysmex Co., Japan) equipped with a 
multispecies software for veterinary use. The following variables were 
measured: hemoglobin concentration (HGB) (g/dL), red blood 
cells (RBC) count (x 106/µL), mean corpuscular volume MCV (fL), white blood 
cells (WBC) count (x 103/µL), 
platelets (PLT) (x 103/µL) count. Plateletcrit (PCT) (%), hematocrit (HCT) (%), mean 
corpuscular hemoglobin MCH (pg/cell), and mean corpuscular hemoglobin concentration 
(MCHC) (g/dL) were calculated automatically from the impedance counts.12
 
Internal quality 
control and calibration were performed monthly with e-check Xe (Sysmex Co.). External 
quality control (RIQUAS Monthly hematology, Randox Laboratories, Crumlin, UK ) was 
also run monthly. In addition, manual differential WBC counts were performed on at least 
200 WBC on blood smears stained with May–Grünwald-Giemsa by 2 different PhD 
students, with at least one year of experience in smear evaluation.  
During the microscopic analysis of blood smears, all blood cells were examined, and the 
percentage of nucleated RBCs (nRBCs), the presence of RBC morphologic 
changes (e.g., anisocytosis or poikilocytosis, Howell-Jolly bodies), quantity and 
morphology of PLT (size, shape, granularity, platelet estimate, platelet clumps), WBC 
morphology (e.g., toxic neutrophils, activated lymphocytes or monocytes), if 
any, were recorded.  
Clinical chemistry: biochemistry profiles were performed using an automated 
chemistry analyzer (Cobas Mira; Roche Diagnostics, Switzerland) and reagents provided 
by Hagen Diagnostic System (Italy). Internal quality control was performed with 2 levels of 
human control serum samples (Precinorm U and Precipath U; Real Time Diagnostic 
System, Italy) before each assay, and calibration was performed with human based 
calibrators (Calibrator; Real Time Diagnostic System). External quality control (RIQAS 
Monthly clinical chemistry, Randox Laboratories) was also run monthly. The serum 
concentration or activity of the following analytes was measured: glucose (GOD-POD 
method), urea (urease method), creatinine (Jaffé method), GGT (γ-
glutamyltransferase, kinetic IFCC method), total protein (biuret method), ALP (alkaline 
phosphatase, kinetic IFCC method), ALT (alanine aminotransferase, kinetic IFCC method), 
calcium (ortho-cresophtalein method), inorganic phosphate (molibdate method), 
triglycerides (GOD-PAP method), and cholesterol (CHOD-POD method), sodium, 
potassium and chloride (ion selective electrodes). Information on the coefficient of 
variations of the hematological and biochemical analytes included in this study are 
reported in the supplemental table S1. 
  
Statistical analysis 
The transference method13 was used to compare the results of 20 Shetland Sheepdogs, 
randomly selected from the dataset, with the RIs of the general canine population in use in 
our laboratory. If less than 10% of values were outside the claimed reference interval, this 
latter RI was validated, while if more than 25% of values were outside the claimed 
reference interval, this latter was rejected. When the proportion of values outside the 
claimed RI was within 10% and 25%, additional 20 results were randomly selected and re-
examined, using the 10% threshold to validate or reject the claimed RI. When the claimed 
RIs were rejected, new reference intervals were calculated according to the ASVCP 
guidelines.11 Based on data distribution, a non-parametric method or the Robust method 
were used to define the reference intervals with 90% confidence interval.  
The RIs were determined using an Excel (Excel; Microsoft Corp., USA) spreadsheet with 
the Reference Value Advisor (version 2.0) set of macroinstructions.14 The 
software performs computations according to the IFCC-CLSI recommendations13 as 
suggested by ASVCP guidelines.11
 
Descriptive statistic, test of normality according to 
Anderson–Darling with histograms and Q-Q plots, and Box–Cox transformation were 
calculated. To find outliers, we used both the Dixon–Reed and the Tukey’s test. Following 
the ASVCP guidelines11,
 
outliers considered as “suspected” by the software were retained. 
Conversely, far outliers were removed from the analysis.  
Differences of all hematological and biochemical results recorded in dogs of different 
sex (excluding neutered females and the castrated male, that were too few to allow a 
reliable statistical comparison), and use (companion vs agility dogs) were investigated with 
a U Mann-Whitney U test, using an Microsoft Excel with the Analyse-it set of 
macroinstructions (Analyse-it software, version 2.21; Analyse-it Software Ltd, UK), 
whereas the possible differences associated with the coat colour (sable, bi-Black, tri-
colour and blue merle) were assessed using a non-parametric ANOVA test (analysis of 
variance) for independent samples (Kruskal-Wallis test) followed by a Bonferroni test in the 
case of significant differences. The possible age-related differences were investigated by 
linear regression using the Reference Value Advisor (version 2.0) set of macroinstructions 
mentioned above. 
  
Results 
Samples from 60 clinically healthy and fasted Shetland Sheepdogs (24 males, 1 neutered 
male, 31 females and 3 spayed females) with a median age of 3,5 years (age range: 1-8 
years), were examined. This caseload represents the 36% of the population registered at 
the National Breed association.2 
All the dogs fulfilled the inclusion criteria described above. No sample was 
hemolytic, icteric or lipemic. Hematologic RIs were determined for 59 samples (one 
sample in EDTA was clotted) whereas sodium, potassium and chloride were only 
evaluated in 40 dogs due to the insufficient volume of the collected serum. Others 
biochemical analyses were performed in all the 60 Shetland Sheepdogs.  
  
Comparison with claimed RIs and establishment of new RIs  
The percentage of observations falling outside the RIs in use in our laboratory is reported 
in Table 1. Based on these results, the transference method validated 15/16 hematological 
and 7/14 biochemical RIs. For 8 analytes, the claimed RIs were rejected and 
new RIs were created (Table 2). Histograms displaying the distribution of data for 
these 8 analytes are reported in the Supplementary Figure 1. 
  
Partitioning based on use, sex, age and color of the coat 
A significant difference (P<0.01) between males (47,3 U/L +/- 27,26) and females (27,5 
U/L +/- 8,94) concerning the activity of ALT was found (Figure 1). No other differences 
related to gender, use or color of the coat were found. 
A weak correlation (Figure 2) was found between serum cholesterol concentration and age 
(-0.026 – p=0.045). 
  
Discussion 
This study suggests that for the large majority of biochemical and hematological analytes, 
the RIs derived from the general canine population may be used also in Shetland 
Sheepdogs. The transference method rejected only 8 RIs. However, as recommended by 
the guidelines for establishing RIs11 the opportunity to apply these newly generated RIs 
may depend also on non-statistical factors. From this perspective, we think that for 6 out of 
8 analytes (platelets, sodium, chloride, phosphate, triglycerides and total protein), pre-
analytical or analytical factors may explain the rejection of claimed RIs using the 
transference method, or the analysis of the newly established reference intervals 
may demonstrate that, despite the results of the transference method, the use of the pre-
existing RIs from the general canine population may be still valid. More specifically, the 
analysis of the distribution of data evidences that the minimum value recorded for sodium 
(and consequently the lower reference limit of the RI), and the maximum values recorded 
for both the sodium and chloride (and consequently the upper and lower reference limits of 
the RIs) are respectively so low and high that sampled animals should have clinical 
signs consistent with electrolyte or acid-base disturbances and possibly changes also in 
the concentration of potassium,15,16 but this was not the case in our sampled 
population. Therefore, the most likely interpretation is that results of sodium and chloride 
were probably affected by analytical artefact. This hypothesis is supported by the fact that 
sodium and chloride were proportionally increased or decreased compared with the 
claimed RIs only in a minority of cases. External and internal quality control runs did not 
reveal analytical problems of the instrument or the method. Therefore, abnormal results 
may depend on sample collection, on sample pre-processing or on the presence of 
interfering substances in the tubes or in serum that affected the measurement of these two 
electrolytes. Despite the nature of this artefact cannot be determined in this study, it may 
be advisable to continue to use the RIs of the general canine population until new studies 
specifically focused on these electrolytes in Shetland Sheepdogs will be run. Similarly, the 
lower reference limit for platelets is too low to not be associated with clinical signs. 
However, falsely low platelet count may frequently occur in dogs, due to the dificulties of 
automated instruments to correctly differentiate platelets from erythrocytes17 or to platelet 
clumping.18 Low platelet counts, usually associated with increased mean platelet volume 
(macrothrombocytopenia) is reported in the Cavalier King Charles Spaniel.19 However, the 
MPV of Shetland Sheepdog was not increased compared with the general canine 
population and the observation of blood smear did not reveal the presence 
of macroplatelets. Conversely, platelet clumps were found in only one sample, and the 
platelet estimate was adequate in all the samples. This suggests that platelet counts may 
have suffered from an analytical artefact that lowered the actual number of platelet present 
on the samples(pseudothrombocytopenia), as often occurs with automate counts based 
on the impedance method.20 Therefore, the lower limit of platelet count should be 
cautiously interpreted and it may be advisable to continue to use the claimed RIs, with the 
recommendation to pay particular attention on the presence of platelet clumps on 
smears. The distribution of data regarding total proteins and phosphate did not evidence 
any possible pre-analytical or analytical artefacts and therefore either the transference 
method or the newly established RIs may be theoretically acceptable. However, either the 
lower or the upper reference limit of both these analytes are so similar to those of the 
general canine population that it may be superfluous to use a different RI and therefore it 
would be more practical to use the RI referred to the general canine population. As a 
support to this hypothesis, for both the analytes, the difference between the claimed and 
the newly established RIs corresponds to the intrinsic variability of the method 
(see supplemental table S1). Finally, the high proportion of samples on which the 
concentration of triglycerides was higher than the claimed RIs likely depends on the 
inadequacy of the latter. The RI in use in our laboratory for triglycerides (38 mg/dL) was 
adopted from Kaneko21 using the method of transference of reference intervals described 
above, but other textbooks or articles report that the upper reference limit for 
this analyte may be as high as 200 mg/dL.22From this standpoint, the maximum value and 
the upper reference limit recorded in this study (86 and 79.7 mg/dL, respectively) may be 
considered as a normal values and, therefore, the use of RIs from the general population 
reported in recent articles may be used also in Shetland Sheepdogs. 
Conversely, breed-specific RIs should be used for glucose and total cholesterol in 
Shetland Sheepdogs to reduce the misinterpretation of laboratory results. In these cases, 
in fact, the presence of pre-analytical or analytical artefacts is unlikely. Theoretically, high 
glucose concentration may depend on stress, possibly associated with sampling or 
travelling to breed meetings, presumably from epinephrine23 or 
cortisol24 secretion. However, no other signs of stress (e.g. lymphopenia) were found 
and the dogs included in this study were accustomed to travelling and to competition. 
Therefore, it may be assumed that the concentration of glucose in this breed is 
constitutively slightly higher than in other dogs. Also the RIs of cholesterol was higher than 
in the general canine population. However, all the dogs presented cholesterol levels lower 
than 500 mg/dL, which is considered as a clinically relevant value.7 However, the RI for 
serum cholesterol (and the confidence interval of its upper limit) were very wide due to the 
presence of a single dog with a concentration of serum cholesterol very close 
to 500 mg/dL and to additional 10 dogs with values ranging from 300 to 400 mg/dL. A 
complete abdominal ultrasound screening was not performed in this dog, and therefore the 
possible presence of occult diseases typical of this breed (e.g. gallbladder mucocele) 
cannot be ruled out. However, ultimately, our results were different to those of Sato and 
others3 that in 64 Shetland Sheepdog found a mean plasma cholesterol level of 335 +/-
 312 mg/dL but in the cited study the presence of diseases than can lead to 
hypercholesterolemia (e.g. hypothyroidism, hyperadrenocorticism) was not 
excluded. According to Graham et al.,5 the prevalence of hypothyroidism in Shetland 
Sheepdog is 14% in a population of 5765 dogs of this breed. However, our study did not 
confirm the primary hypertriglyceridemia reported by Aguirre et al.4 or the presence of 
primary hyperlipidemia that was demonstrated in other studies such as those of Sato et 
al.3 mentioned above or of Mori et al.25 that found high concentrations of both triglycerides 
and total cholesterol but in samples obtained from non-fasted dogs on which 
the higher serum concentration of both the analytes may also depend on feeding. 
However, a trend to hypercholesterolemia was found in many of the in outwardly clinically 
healthy Shetland Sheepdogs included in the current study. Therefore, further studies are 
needed to investigate if primary hyperlipidemia may occur in this breed. This may be 
interesting since primary hyperlipidemia has been reported as a possible predisposing 
factor for gallbladder disorders, that are common in this breed.4 
According to our results, cholesterol concentration appeared to decrease with the 
increasing age. This result appears to be not justified by biological causes; moreover, the 
correlation is very weak. In any case, this result contrasts with what reported by Mori et 
al.25 that found a positive correlation between the severity of hyperlipidemia and aging in 
Shetland Sheepdogs. 
No other age related differences were found, likely because very young or old dogs, that 
may usually have evident differences regarding hematological or 
biochemical analytes compared with adult dogs, were not included in this study. 
As regards gender related activities, Mori et al.25 found that hypertriglyceridemia was more 
frequent in females whereas in male prevails the hypercholesterolemia. However, the 
result of the current study did not confirm this finding. Conversely, the presence of 
significant gender-related differences of ALT activity recorded in the current study was not 
reported in previous studies. Mean and median values were within the RI of the general 
canine population in both groups; clinical signs potentially associated with hepatocellular 
damage (e.g. e.g. apathy, inappetence, jaundice, vomiting, acholic feces, weight loss, 
polyuria/polydipsia, distended abdomen)26 were never detected in this study even if 
sometimes it is not possible to rule out an hepatocellular injury without further diagnostic 
procedures (ultrasound examination and liver biopsy). Therefore, in the absence of an 
evident explanation about its possible pathogenesis, this finding could be considered 
as non-biologically relevant. 
In conclusion, this study suggests that breed-specific RIs may be used for glucose and 
cholesterol in Shetland Sheepdogs to reduce the misinterpretation of laboratory results. 
This confirms that the recommendation to generate, for some analyte, breed-specific 
reference intervals, as suggested recently either in dogs27,28 or in cats,29,30may be valid also 
in this breed. 
However, the current study demonstrated some additional peculiarities, such as a 
significant difference between male and female for ALT activity. Conversely, this 
study didn’t confirm the presence of primary hyperlipidemia in Shetland Sheepdogs, 
although it may be advisable, in routine practice, to monitor the dogs with cholesterol 
values close to upper limit the newly generated RIs, to exclude the possible presence of 
occult or upcoming gallbladder disease. 
These conclusions could be a starting point to further investigations about this breed 
and the possible predisposition of Shetland Sheepdogs to different diseases. 
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Table 1. Canine RIs in use in our laboratory and results of the transference method: the 
percentage of 20 or 40 (when the first 20 values were included in the claimed 
RIs) randomly selected observations falling outside the claimed RI is reported.  
Analyte % Of results falling outside the claimed 
RIs  (1st and 2nd analysis) 
Claimed RIs in use at our 
laboratory  
Glucose 30% 80.0-100.0 mg/dL 
Urea 0% 20.0-60.0 mg/dL 
Creatinine 0% <1.5 mg/dL 
Sodium 35% 141-152 mmol/L 
Potassium 5% 3.7-5.8 mmol/L 
Calcium 5% 8.0-12.0 mg/dL 
Phosphate 30% 3.5-6.2 mg/dL 
Chloride 50% 105.0-115.0 mmol/L 
Cholesterol 45% 135.0-270.0 mg/dL 
Triglycerides 55% <38.0 mg/dL 
ALT 10% <60.0 U/L 
ALP 10% <180.0 U/L 
GGT 0% <14.0 U/L 
Total Protein 20% (30%) 5.4-7.5 g/dL 
RBC 10% 5.7-8.8 x106/µL 
HGB 5% 12.9-18.4 g/dL 
HCT 10% 37.0-57.0 % 
Platelets 20% (30%) 200.0-500.0 x103/µL 
MCHC 10% 310.0-360.0 g/L 
MCH 0% 19.5-24.2 pg 
MCV 10% 60.0-77.0 fL 
WBC 10% 6.0-19.5 x 103/µL 
Neutrophil 5% 3.0-11.5 x103/µL 
Eosinophil 10% 0.1-1.2 x103/µL 
Lymphocyte 5% 1.0-4.8 x103/µL 
Monocyte 5% 0.1-1.5 x103/µL 
RDW 0% 11.9-18.5 fL 
PCT 10% 0.2-0.4% 
MPV 20% (5%) 8.0-13.0 fL 
PDW 15% (5%) 8.0-18.0 fL 
  
Data in bold indicates the analytes for which the claimed RIs were rejected since the 
percentage of observations falling outside the claimed RI was >25% at first analysis or 
>10% in two consecutive analyses of the dataset. 
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Table 2. Newly established RIs of the analytes for which the claimed RIs were rejected. 
Analyte N Mea
n 
Medi
an 
SD Min Max Ou
t 
RI 90% 
CI 
(LR
L) 
90% 
CI 
(UR
L) 
Dis
t. 
Met
h 
Glucose(mg/dL) 6
0 
109.
9 
108.5 16.
0 
82.
0 
151
.0 
1 
(S) 
83.1
-
150.
0 
82.0
-
85.6 
137.
0-
151.
0 
G NP 
Sodium(mmol/L
) 
4
0 
145.
8 
145.0 7.0 130
.0 
161
.0 
1 
(S) 
130-
160.
9 
130.
0-
133.
0 
154.
0-
161.
0 
G NP 
Phosphate(mg/
dL) 
5
9 
4.0 4.1 0.5 3.0 5.7 1 
(R)
3.1-
5.4 
3.1-
3.4 
4.8-
5.7 
G NP 
. 
1 
(S) 
Chloride(mmol/
L) 
3
6 
113.
8 
115.0 6.3 95.
0 
125
.0 
3 
(S) 
102.
3-
128.
7 
98.2
-
106.
4 
124.
6-
129.
1 
NG Ro
b 
Total 
Cholesterol(mg/
dL) 
6
0 
241.
2 
233.5 74.
1 
112
.0 
468
.0 
1 
(S) 
116.
7-
420.
8 
112.
0-
130.
9 
360.
4-
468.
0 
G NP 
Triglycerides(m
g/dL) 
6
0 
43.3 40.0 12.
8 
28 86.
0 
3 
(S) 
28.0
-
79.7 
28.0
-
29.0 
69.0
-
86.0 
NG NP 
Total 
protein(g/dL) 
5
9 
6.1 5.9 0.8 5.0 8.0 1 
(R)
. 
2 
(S) 
5.1-
8.0 
5.0-
5.2 
7.6-
8.0 
NG NP 
Platelets 
(x 103/µL) 
5
8 
276.
1 
275.5 91.
1 
13.
0 
503
.0 
2 
(S)
   
57.7
-
487.
8 
13-
146.
1 
428.
3-
503.
0 
G NP 
  
N = number of valid observations; SD = standard deviation, Out = outliers; RI = reference 
interval; LRL = lower reference limit; URL = upper reference limit; Dist = distribution; Meth 
= method; (S) = number of suspected outliers; (R) = number of far outliers that were 
identified and removed; G = gaussian; NG = non Gaussian; NP = non parametric; Rob = 
robust method 
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Figure captions 
Figure 1. Difference between males (M) and females (F) concerning the activity of serum 
ALT. The boxes indicate the I–II interquartile range (IQR), the horizontal line indicates the 
median values, whiskers extend to further observation within quartile I minus 1.5 × IQR or 
to further observation within quartile III plus 1.5 × IQR. ‘+’ indicates near outliers 
(i.e. values exceeding quartiles I or III minus or plus 1.5 × IQR); the asterisks indicate far 
outliers (i.e. values exceeding quartiles I or III minus or plus 1.5 × IQR). 
  
Figure 2. Scatter plot representing the negative correlation between 
cholesterol concentration (Tot Cho) and age. A weak correlation was found (-0.026 – 
p=0.045). 
  
Supplemental figure S1. Distribution of 8 hematological and biochemical values recorded 
in our study and that need new RIs in Shetland sheepdog. For each analyte, the observed 
and fitted distribution are reported (blue bars and pink line, respectively). The blue vertical 
lines indicate the upper and lwer limit of the reference intervals. The 90% CI of both the 
reference limits are indicated by the dotted lines. 
 
 
 
	 
	
